-+ 0.00%
-+ 0.00%
-+ 0.00%

CHEMOMAB THERAPEUTICS AND PRECISION MEDICINE PIONEER SCIPHER MEDICINE ANNOUNCE MERGER AGREEMENT TO ADVANCE NEBOKITUG IN AN AI-POWERED PHASE 2 TRIAL IN RHEUMATOID ARTHRITIS

Reuters·07/08/2026 11:35:54

Please log in to view news